Effects of Fufang Shenhua Tablet (复方肾华片) on the expression of toll-like receptors during acute kidney injury induced by ischemia-reperfusion in rats
Back to article page
OriginalPaper|Updated:2021-08-27
|
Effects of Fufang Shenhua Tablet (复方肾华片) on the expression of toll-like receptors during acute kidney injury induced by ischemia-reperfusion in rats
Effects of Fufang Shenhua Tablet (复方肾华片) on the expression of toll-like receptors during acute kidney injury induced by ischemia-reperfusion in rats
中国结合医学杂志(英文版)2012年18卷第12期 页码:918-924
Affiliations:
Nephropathy of Chinese PLA General Hospital, State Discipline and Key Laboratory of Kidney Disease (Chinese PLA General Hospital 2011DAV),Beijing,China,00088
Author bio:
Funds:
Supported by the National Natural Science Foundation of China (No. 81072914 and 81273968);Major Project Foundation of National Science and Technology (No. 2010ZX9102-204);and Traditional Chinese Medicine Research Grant for Military Organization (No. 10ZYZ255)
Zheng, Xy., Wei, Rb., Shi, Sz. et al. Effects of Fufang Shenhua Tablet (复方肾华片) on the expression of toll-like receptors during acute kidney injury induced by ischemia-reperfusion in rats., Chin. J. Integr. Med. 18, 918–924 (2012). https://doi.org/10.1007/s11655-012-1295-1
Xiao-yong Zheng, Ri-bao Wei, Suo-zhu Shi, et al. Effects of Fufang Shenhua Tablet (复方肾华片) on the expression of toll-like receptors during acute kidney injury induced by ischemia-reperfusion in rats[J]. Chinese Journal of Integrative Medicine, 2012,18(12):918-924.
Zheng, Xy., Wei, Rb., Shi, Sz. et al. Effects of Fufang Shenhua Tablet (复方肾华片) on the expression of toll-like receptors during acute kidney injury induced by ischemia-reperfusion in rats., Chin. J. Integr. Med. 18, 918–924 (2012). https://doi.org/10.1007/s11655-012-1295-1DOI:
Xiao-yong Zheng, Ri-bao Wei, Suo-zhu Shi, et al. Effects of Fufang Shenhua Tablet (复方肾华片) on the expression of toll-like receptors during acute kidney injury induced by ischemia-reperfusion in rats[J]. Chinese Journal of Integrative Medicine, 2012,18(12):918-924. DOI: 10.1007/s11655-012-1295-1.
Effects of Fufang Shenhua Tablet (复方肾华片) on the expression of toll-like receptors during acute kidney injury induced by ischemia-reperfusion in rats
摘要
To investigate the impact of a traditional Chinese medicinal compound known as Fufang Shenhua Tablet (复方肾华片
SHP) on the expression of Toll-like receptors (TLRs) during renal ischemia-reperfusion injury (IRI)-induced acute kidney injury (AKI) in rats. A total of 28 Wistar rats were randomly divided into five groups: (1) pseudo-operation control group
(2) ischemia-reperfusion model group
(3) Astragaloside group
(4) high-dose SHP group
and (5) low-dose SHP group. There were four rats in the pseudo-operation group and six rats in each of the other groups. The accepted ischemia-reperfusion model was established after a 7-day gavage intervention
and pathological changes and renal function were observed
using an enzyme-linked immunosorbent assay (ELISA) to detect interleukin 8 (IL-8) and interferon gamma (IFN-γ) levels
as well as immunohistochemical staining to detect altered levels of TLR2 and TLR4 expression in renal tissue. After 24 h
renal pathological damage and the expression levels of serum creatinine (Scr)
IL-8
IFN-γ
TLR2
and TLR4 were significantly higher in the model group as compared with the pseudo-operation group (P<0.05). In addition
at 24 h the above indicators decreased significantly in the Astragaloside group
high-dose SHP group and low-dose SHP group as compared with the ischemia-reperfusion model group (P< 0.05). TLR2 and TLR4 expression levels were significantly reduced in the SHP treatment and Astragaloside group as compared with the pseudo-operation group (P<0.05). Further
the high-dose SHP group showed significantly less renal damage score and decreased levels of TLR expression than those of low-dose SHP group and Astragaloside group (all P<0.05). SHP can alleviate the renal structural and functional damage caused by IRI-induced AKI in rats by reducing the damage of renal pathology
which may reduce inflammatory cytokine levels by downregulating the expression of TLRs in renal tissue in a dose-dependent manner.
Abstract
To investigate the impact of a traditional Chinese medicinal compound known as Fufang Shenhua Tablet (复方肾华片
SHP) on the expression of Toll-like receptors (TLRs) during renal ischemia-reperfusion injury (IRI)-induced acute kidney injury (AKI) in rats. A total of 28 Wistar rats were randomly divided into five groups: (1) pseudo-operation control group
(2) ischemia-reperfusion model group
(3) Astragaloside group
(4) high-dose SHP group
and (5) low-dose SHP group. There were four rats in the pseudo-operation group and six rats in each of the other groups. The accepted ischemia-reperfusion model was established after a 7-day gavage intervention
and pathological changes and renal function were observed
using an enzyme-linked immunosorbent assay (ELISA) to detect interleukin 8 (IL-8) and interferon gamma (IFN-γ) levels
as well as immunohistochemical staining to detect altered levels of TLR2 and TLR4 expression in renal tissue. After 24 h
renal pathological damage and the expression levels of serum creatinine (Scr)
IL-8
IFN-γ
TLR2
and TLR4 were significantly higher in the model group as compared with the pseudo-operation group (P<0.05). In addition
at 24 h the above indicators decreased significantly in the Astragaloside group
high-dose SHP group and low-dose SHP group as compared with the ischemia-reperfusion model group (P< 0.05). TLR2 and TLR4 expression levels were significantly reduced in the SHP treatment and Astragaloside group as compared with the pseudo-operation group (P<0.05). Further
the high-dose SHP group showed significantly less renal damage score and decreased levels of TLR expression than those of low-dose SHP group and Astragaloside group (all P<0.05). SHP can alleviate the renal structural and functional damage caused by IRI-induced AKI in rats by reducing the damage of renal pathology
which may reduce inflammatory cytokine levels by downregulating the expression of TLRs in renal tissue in a dose-dependent manner.
Bajwa A, Jo SK, Ye H, Huang L, Dondeti KR, Rosin DL, et al. Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia reperfusion injury. J Am Soc Nephrol 2010;21:955–965.
Wei Q, Bhatt K, He HZ, Mi QS, Haase VH, Dong Z. Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2010;21:756–761.
Arumugam TV, Okun E, Tang SC, Thundyil J, Taylor SM, Woodruff TM. Toll-like receptors in ischemia-reperfusion injury. Shock 2009;32:4–16.
Li J, Hu SJ. The advancement of Chinese medicine prevention renal ischemical reperfusion injury. Global Tradit Chin Med (Chin) 2009;2:223–225.
Yu QC, Zhu TY, Zhang YK, Zhang L, Guan JM. Effect of Astrgaloside IV on long-term MCP-1 expression in renal ischemia-reperfusion injury in the rat. Fudan Univ J Med Sci (Chin) 2004;31:588–591.
Zhang PJ, Jin C, Lang J, Pu P, Zhang J, Su H, et al. Effect of Atractylodes MacrocephaIaon polysaccharides for reducing liver ischemia/reperfusion injury in rats after orthotopic liver autotransplantation. Chin J Integr Tradit West Med (Chin) 2010;30:1193–1196.
Chen XM, Chen J, Chen YP, Zhou ZL, He YN, Li P, et al. Multicentered, randomized, controlled clinical trial on patients with IgA nephropathy of qi-yin deficiency syndrome type. Chin J Integr Tradit West Med (Chin) 2007;27:101–105.
Zhang WX, Chen XM, Wei RB, Shi SZ, Hong Q, Zhang XG. Effect of Shenhua on expression and activation of Stat3 in kidney tissue of chronic glomerulonephritis rats. Chin J Integr Tradit West Med (Chin) 2005;25:66–70
Byung SK, Sun WL, Li C, Jung SK, Bo KS, Kyung OA. Ischemia-Reperfusion injury activates innate immunity in rat kidneys. Transplantation 2005;79:1370–1377.
Yamada K, Miwa T, Liu J, Nangaku M, Song WC. Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol 2004;172:3869–3875.
Zhang B, Ramesh G, Uematsu S, Akira S, Reeves WB. TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J Am Soc Nephrol 2008;19:923–932.
MacLeod H, Wetzler LM. T cell activation by TLRs: a role for TLRs in the adaptive immune response. Sci STKE 2007;402:pe48.
Chen H, Hu XS. Advances in research on mechanism of TCM for invigorating blood and enriching qi working against renal ischemic-reperfusion injury. Global Tradit Chin Med (Chin) 2012;5:63–66,71.
Song JY, Meng LQ, Li XM. Therapeutic application and prospect of Astragalus membranaceus and Angelica sinensis in treating renal microvascular lesions. Chin J Integr Tradit West Med (Chin) 2008;28:859–861.
Effect of acupuncture on proliferation and differentiation of neural stem cells in brain tissues of rats with traumatic brain injury
Reciprocal effects of Guizhi decoction (桂枝汤) to the Guizhi decoction syndrome by toll-like receptor mRNA expression and cytokines secretion
Scavenging effect of Naoerkang (脑尔康) on amyloid beta-peptide deposition in the hippocampus in a rat model of Alzheimer’s disease
Effect of Qiangxin Fumai Granule (强心复脉颗粒) on electrophysiological functions of the sinoatrial node during ischemia-reperfusion of the right coronary artery in rabbits
Effect of Yiqi Huoxue Recipe (益气活血方) on cardiac function and ultrastructure in regression of pressure overload-induced myocardial hypertrophy in rats
相关作者
暂无数据
相关机构
Guangzhou University of Traditional Chinese Medicine
Jinan University
Wangjing Hospital, China Academy of Chinese Medical Sciences
Tang Center for Herbal Medicine Research, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
Department of Geriatrics, Fuzhou General Hospital of Nanjing Military District